Dr Reddy’s tablets in US
Dr. Reddy’s Laboratories Ltd has launched Lamotrigine Orally Disintegrating Tablets in 25 mg, 50 mg, 100 mg, and 200 mg, a therapeutic equivalent generic version of Lamictal® ODT (lamotrigine) Orally Disintegrating Tablets in the United States market.
Approved by the U.S. Food & Drug Administration (USFDA), the Lamotrigine Orally Disintegrating Tablets 25 mg, 50 mg, 100 mg, and 200 mg are available in bottle count sizes of 30s.
Lamictal® ODT is a registered trademark of GSK group of companies. fii-news.com